Comments on: Emisphere Signs License Agreement with Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications

Comments on: Emisphere Signs License Agreement with Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications /contractors/drug-delivery/emisphere-technologies/pressreleases/presslicense-agreement-novo-nordisk-oral-formulations/ The leading site for news and procurement in the pharmaceutical industry Fri, 23 Oct 2015 03:14:00 +0000 hourly 1 https://wordpress.org/?v=6.7.2